CMV-MVA Triplex Vaccination
Placebo-Controlled and Randomized Phase 2 Trial of CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors to Enhance CMV-Specific Immunity and Prevent CMV Viremia in Recipients After Hematopoietic Stem Cell Transplant
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 2
- Enrollment
- 216 patients (estimated)
- Sponsors
- City of Hope Medical Center
- Collaborators
- National Cancer Institute (NCI)
- Tags
- Allogeneic Stem Cell Transplant, Vaccine, Placebo, Randomization
- Trial Type
- Treatment
- Last Update
- 4 months ago
- SparkCures ID
- 1776
- NCT Identifier
- NCT06059391
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.